Relationship between mutations in the DNA gyrase and topoisomerase IV genes and nadifloxacin resistance in clinically isolated quinolone-resistant Staphylococcus aureus

Journal of Infection and Chemotherapy

Volumn 7, Issue 3, 2001, Pages 191-194

  Oizumi, N ^a   Kawabata, S ^a   Hirao, M ^a   Watanabe, K ^a   Okuno, S ^a   Fujiwara, T ^a   Kikuchi, M ^a  

^a OTSUKA PHARMACEUTICAL CO LTD   (Japan)

Author keywords

DNA gyrase; Fluoroquinolone resistance; Nadifloxacin; norA; Staphylococcus aureus; Topoisomerase IV

Indexed keywords

CIPROFLOXACIN; DNA TOPOISOMERASE (ATP HYDROLYSING); DNA TOPOISOMERASE IV; ENOXACIN; GENE PRODUCT; LEVOFLOXACIN; LOMEFLOXACIN; NADIFLOXACIN; NORFLOXACIN; OFLOXACIN; PROTEIN NORA; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SPARFLOXACIN; TOSUFLOXACIN; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; CORRELATION FUNCTION; ENZYME SUBUNIT; GENE MUTATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; STAPHYLOCOCCUS AUREUS;

EID: 0034756083     PISSN: 1341321X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s101560100034     Document Type: Article

References (15)

1. Quinolone mode of action
2. Detection of novel mutations in the gyrA gene of Staphylococcus aureus by nonradioisotopic single-strand conformation polymorphism analysis and direct DNA sequencing
3. Cloning and primary structure of Staphylococ-Cus aureus DNA topoisomerase IV: A primary target of fluoroquinolones
4. Analysis of gyrA and grlA mutations in stepwise-selected ciprofloxacin-resistant mutants of Staphylococcus aureus
5. The gr1A mutation in norfloxacin-resistant first-step mutants and clinical isolates of Staphylococcus aureus
6. Alterations in the DNA topoisomerase IV grlA gene responsible for quinolone resistance in Staphylococcus aureus
7. Comparison of inhibition of Escherichia coli topoisomerase IV by quinolones with DNA gyrase inhibition
8. Quinolone-resistant mutants of Escherichia coli DNA topoisomerase IV parC gene
9. Primary targets of fluoroquinolones in Streptococcus pneumoniae
10. Targeting of DNA gyrase in Streptococcus pneumoniae by sparfloxacin: Selective targeting of gyrase or topoisomerase IV by quinolones
11. Efflux-mediated fluoroquinolone resistance in Staphylococcus aureus
12. Sensitivity of Staphylococcus aureus, isolated from skin infections in 1994, to 19 antimicrobial agents
13. Nucleotide sequence of the Staphylococcus aureus gyrB-gyrA locus encoding the DNA gyrase A and B proteins
14. Quinolone resistance mutations in the DNA gyrase gyrA and gyrB genes of Staphylococcus aureus
15. Inducible NorA-mediated multidrug resistance in Staphylococcus aureus